VIM and non-small cell lung carcinoma: The fact that CytoMAD can detect the small amount of cell population indicative of exhibiting the EpCAM+Vim+ phenotype (≈4%) in early‐stage NSCLC patients may suggest early evidence for the phenotypic transformation required for metastasis.